Announcements Trials
Browse Landscape

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 1Breast 1

Conditions

Breast Neoplasms 16Venous Thromboembolism 1Neoplasm Metastasis 1HR+HER2- Advanced Breast Cancer 1DILI 1Cardiovascular Diseases 1Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors 1Breast Neoplasms, Male 1Breast Diseases 1

Interventions

Rivaroxaban 5apixaban 4Heparin, Low-Molecular-Weight 2Dabigatran 2ribociclib 1palbociclib 1edoxaban 1calcium heparin 1abemaciclib 1Tinzaparin 1Surveys and Questionnaires 1Observation 1Nadroparin 1Mass Screening 1Heparin 1Fondaparinux 1Enoxaparin 1Data Collection 1Dalteparin 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Venous Thromboembolism × ribociclib × Clear all
NCT07008508 2025-06-06

BRAVE-Cyclin

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Active not recruiting
300 enrolled
BreastClassical hematology

Breast Neoplasms, Cardiovascular Diseases, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡